How many studies have been conducted on Guanylyl Imidodiphosphate?

BiohacksAI has indexed 300 PubMed studies on Guanylyl Imidodiphosphate. 3% of studies involve human subjects.

What are the main research areas for Guanylyl Imidodiphosphate?

The primary research domains for Guanylyl Imidodiphosphate are 🦴 Bone & Joint, 🧠 Focus & Attention, 🌤️ Mood & Depression. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Guanylyl Imidodiphosphate

A non-hydrolyzable analog of GTP, in which the oxygen atom bridging the beta to the gamma phosphate is replaced by a nitrogen atom. It binds tightly to G-protein in the presence of Mg2+. The nucleotide is a potent stimulator of ADENYLYL CYCLASES.

300+ PubMed studies analyzed · Evidence Score: 41.6

Research Domains

Guanylyl Imidodiphosphate has been studied across 20 research domains including 🦴 Bone & Joint, 🧠 Focus & Attention, 🌤️ Mood & Depression, 🫘 Kidney, 🧬 Hormones. The primary research focus is 🦴 Bone & Joint with 14% of studies addressing this area.

Loading evidence profile...

This evidence profile for Guanylyl Imidodiphosphate is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.